Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea

IntroductionWe aimed to compare and analyze the cost-effectiveness of laparoscopic vs. open colorectal surgery (CRS) for colorectal cancer using health insurance claims data derived from multiple institutions in South Korea as well as the differences in hospital length of stay (LOS) and 30-day readm...

Full description

Saved in:
Bibliographic Details
Main Authors: Sanghyun An, Sung Eun Hong, Moo Hyun Kim, Ik Yong Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2025.1543920/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593926478888960
author Sanghyun An
Sung Eun Hong
Moo Hyun Kim
Ik Yong Kim
author_facet Sanghyun An
Sung Eun Hong
Moo Hyun Kim
Ik Yong Kim
author_sort Sanghyun An
collection DOAJ
description IntroductionWe aimed to compare and analyze the cost-effectiveness of laparoscopic vs. open colorectal surgery (CRS) for colorectal cancer using health insurance claims data derived from multiple institutions in South Korea as well as the differences in hospital length of stay (LOS) and 30-day readmission rates related to postoperative complications.MethodsWe retrospectively reviewed the clinical data of patients who underwent curative resection for colorectal cancer between January 1, 2020 and December 31, 2022 using national health insurance claims data in South Korea. We determined the surgical approach based on the presence or absence of treatment material codes specific to laparoscopic surgery, and divided the patients into the laparoscopic-CRS (lap-CRS) and open-CRS groups.ResultsA total of 34,779 patients were included [open-CRS: 3,262 patients [9.4%]; lap-CRS: 31,517 patients [90.6%]]. The mean LOS was 14.11 and 11.27 days for the open- and lap-CRS groups, respectively (p < 0.001). The mean medical costs were 9,163 USD and 8,963 USD in the open- and lap-CRS groups, respectively (p < 0.001). A total of 1,192 (3.4%) patients were readmitted within 30 days of discharge, with a rate of 5.4% (176 cases) and 3.2% (1,016 cases) in the open- and lap-CRS groups, respectively (p < 0.001). Open surgery, male sex, and rectal surgery were identified as factors that increased medical cost.DiscussionAccording to this South Korean nationwide population-based study, laparoscopic surgery demonstrated a reduction in LOS, medical costs, and readmission rates compared with open surgery in patients with colorectal cancer.
format Article
id doaj-art-5b802e41d38a46378887d866376c5d17
institution Kabale University
issn 2296-875X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj-art-5b802e41d38a46378887d866376c5d172025-01-20T07:19:55ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2025-01-011210.3389/fsurg.2025.15439201543920Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South KoreaSanghyun An0Sung Eun Hong1Moo Hyun Kim2Ik Yong Kim3Department of Colorectal Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of KoreaReview and Assessment Division, Seoul Branch Office, Health Insurance Review and Assessment Service, Seoul, Republic of KoreaDepartment of Colorectal Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of KoreaDepartment of Colorectal Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of KoreaIntroductionWe aimed to compare and analyze the cost-effectiveness of laparoscopic vs. open colorectal surgery (CRS) for colorectal cancer using health insurance claims data derived from multiple institutions in South Korea as well as the differences in hospital length of stay (LOS) and 30-day readmission rates related to postoperative complications.MethodsWe retrospectively reviewed the clinical data of patients who underwent curative resection for colorectal cancer between January 1, 2020 and December 31, 2022 using national health insurance claims data in South Korea. We determined the surgical approach based on the presence or absence of treatment material codes specific to laparoscopic surgery, and divided the patients into the laparoscopic-CRS (lap-CRS) and open-CRS groups.ResultsA total of 34,779 patients were included [open-CRS: 3,262 patients [9.4%]; lap-CRS: 31,517 patients [90.6%]]. The mean LOS was 14.11 and 11.27 days for the open- and lap-CRS groups, respectively (p < 0.001). The mean medical costs were 9,163 USD and 8,963 USD in the open- and lap-CRS groups, respectively (p < 0.001). A total of 1,192 (3.4%) patients were readmitted within 30 days of discharge, with a rate of 5.4% (176 cases) and 3.2% (1,016 cases) in the open- and lap-CRS groups, respectively (p < 0.001). Open surgery, male sex, and rectal surgery were identified as factors that increased medical cost.DiscussionAccording to this South Korean nationwide population-based study, laparoscopic surgery demonstrated a reduction in LOS, medical costs, and readmission rates compared with open surgery in patients with colorectal cancer.https://www.frontiersin.org/articles/10.3389/fsurg.2025.1543920/fullcolorectal neoplasmscolorectal surgeryhospital costshospital readmissionlaparoscopy
spellingShingle Sanghyun An
Sung Eun Hong
Moo Hyun Kim
Ik Yong Kim
Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
Frontiers in Surgery
colorectal neoplasms
colorectal surgery
hospital costs
hospital readmission
laparoscopy
title Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
title_full Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
title_fullStr Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
title_full_unstemmed Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
title_short Cost-effectiveness and readmission rates of laparoscopic vs. open surgery for colorectal cancer: evidence from the health insurance review and assessment service dataset in South Korea
title_sort cost effectiveness and readmission rates of laparoscopic vs open surgery for colorectal cancer evidence from the health insurance review and assessment service dataset in south korea
topic colorectal neoplasms
colorectal surgery
hospital costs
hospital readmission
laparoscopy
url https://www.frontiersin.org/articles/10.3389/fsurg.2025.1543920/full
work_keys_str_mv AT sanghyunan costeffectivenessandreadmissionratesoflaparoscopicvsopensurgeryforcolorectalcancerevidencefromthehealthinsurancereviewandassessmentservicedatasetinsouthkorea
AT sungeunhong costeffectivenessandreadmissionratesoflaparoscopicvsopensurgeryforcolorectalcancerevidencefromthehealthinsurancereviewandassessmentservicedatasetinsouthkorea
AT moohyunkim costeffectivenessandreadmissionratesoflaparoscopicvsopensurgeryforcolorectalcancerevidencefromthehealthinsurancereviewandassessmentservicedatasetinsouthkorea
AT ikyongkim costeffectivenessandreadmissionratesoflaparoscopicvsopensurgeryforcolorectalcancerevidencefromthehealthinsurancereviewandassessmentservicedatasetinsouthkorea